WT mice treated with STING activators were more sensitive to steatohepatitis than STING-/- mice, indicating that the cGAS-STING signaling pathway exerts an essential role in the NASH induction. This evidence concerns the gene STING1 and metabolic dysfunction-associated steatohepatitis.